Skip to content

Effect of TMS on different symptoms of Parkinsons Disease

Evaluation of pattern of behaviour in subtypes of Parkinsons Disease in response to non-invasive brain stimulation - TMS-PD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023892
Enrollment
45
Registered
2020-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: real TMS: 7 days. 2 hour rTMS/ day and 2 hour evaluation/ assessment session on first and last day. Control Intervention1: Sham TMS: 7 days. 2 hour rTMS/ day and 2 hour evaluation/ asse

Sponsors

ICMR Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia); 2. PWP of both gender with H&Y stage from 1 to 2.5 3. PWP between age 45 to 75 on stable medication for at least 30 days. 4. Controls: Healthy adults of both gender aged 45-60

Exclusion criteria

Exclusion criteria: 1. Features suggestive of other causes of Parkinsonism/ Parkinson-plus syndromes; 2. History of ICSOL (intracranial space occupying lesion) or brain surgeries, significant headaches, epilepsy or seizure disorder, mass lesions, or major head trauma leading to loss of consciousness of any length; 3. Family (1st degree relatives) history of epilepsy; 4. Presence of contraindications for functional magnetic resonance imaging (fMRI) like metal implants, and claustrophobia; 5. History of schizophrenia, schizoaffective disorder, other psychosis, rapid-cycling bipolar illness, alcohol/drug abuse within the past year; 6. Need for rapid clinical response due to conditions such as psychosis, or suicide tendency; 7. PWP with uncontrolled hypertension and diabetes and other uncontrolled medical illness. PWP with hypertension or diabetes would be included only if they are stable on medication for last six months.

Design outcomes

Primary

MeasureTime frame
UPDRS; LED; PDQ 39Timepoint: Day 0 Day 7

Secondary

MeasureTime frame
MRCP, r-fMRITimepoint: Day 0 Day 7

Countries

India

Contacts

Public ContactPriyanka Bhat

AIIMS

drvinaygoyal@gmail.com1126594210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026